Sotera Health Company (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Brokerages

Sotera Health Company (NASDAQ:SHC) has been given an average rating of “Moderate Buy” by the eleven analysts that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $20.1429.

Several research firms recently weighed in on SHC. Piper Sandler upgraded Sotera Health from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $17.00 to $24.00 in a research note on Friday, January 9th. Zacks Research cut Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Barclays lowered their price target on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th.

Sotera Health Stock Up 1.5%

SHC stock opened at $15.81 on Tuesday. Sotera Health has a fifty-two week low of $10.68 and a fifty-two week high of $19.85. The business’s 50 day moving average price is $15.15 and its two-hundred day moving average price is $16.50. The company has a debt-to-equity ratio of 3.66, a quick ratio of 2.24 and a current ratio of 2.46. The company has a market capitalization of $4.51 billion, a price-to-earnings ratio of 58.56 and a beta of 1.88.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. As a group, analysts forecast that Sotera Health will post 0.88 earnings per share for the current fiscal year.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction on Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the sale, the director owned 12,735,301 shares in the company, valued at approximately $194,468,046.27. This represents a 43.98% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. IFP Advisors Inc boosted its holdings in shares of Sotera Health by 1,105.6% during the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares during the last quarter. Rothschild Investment LLC bought a new stake in Sotera Health in the fourth quarter worth about $27,000. Root Financial Partners LLC lifted its stake in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after purchasing an additional 1,455 shares during the last quarter. True Wealth Design LLC lifted its stake in Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after purchasing an additional 1,456 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.